Our study showed that the EGFR mutation group was associated with aggressive clinicopathological features such as older age, non-lepidic histological subtype, higher rate of pleural and lymphovascular invasion, higher serum CEA level, tumor histological grade, and T stage, and more advanced pathological stage. Here, CEACAM5 is linked to neoplasm.